15 Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP registry data

Saved in:

Bibliographic Details
Published in	Journal of Crohn's and colitis Vol. 7; pp. S7 - S8
Main Authors	Baldassano, R., Colletti, R., Cucchiara, S., Dubinsky, M., Escher, J., Faubion, W., Fell, J., Gold, B., Griffiths, A., Hyams, J., Koletzko, S., Kugathasan, S., Markowitz, J., Ruemmele, F.M., Veereman, G., Callegari, P., Molenda, M., Tang, K.L., Wright, R., Winter, H.
Format	Journal Article
Language	English
Published	Elsevier B.V 01.02.2013
Online Access	Get full text

Loading…

More Information
ISSN:	1873-9946 1876-4479
DOI:	10.1016/S1873-9946(13)60016-1